Hilde Vanaken PhD

Hilde is a Director of the Janssen Clinical Innovation department at Janssen. She has more than 16 years of experience in pharmaceutical companies and Clinical Research Organizations, where she held various leading positions in clinical operations, data management, safety management, professional affairs, quality management, strategic business improvement and clinical trial innovation. Prior to clinical research, Hilde worked as a research scientist for 6 years.

Hilde has a passion for complex and mission impossible projects and has a track record to transform them into success stories. In her current role, Hilde laid the foundation of several transformational projects, such as eConsent, eSource and Integrated Smart Trial and Engagement Program (iSTEP), to modernize Janssen’s clinical trials and improve the experience of patients and investigators. Next to her role in Janssen, Hilde also leads the cross-pharma Transcelerate eConsent initiative to facilitate the cross-industry adoption of eConsent in close collaboration with external stakeholders such as patients, sites, IEC/IRBs and HAs.

Hilde holds a degree in Engineering in Chemical and Agricultural Sciences, a Master in Environmental Sciences and a PhD in Medical Sciences, all from the Catholic University of Leuven in Belgium